HWM
RVMD icon

Hemington Wealth Management’s Revolution Medicines RVMD Stock Holding History

Hemington Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2K Buy
49
+18
+58% +$705 ﹤0.01% 1365
2025
Q2 		$1K Buy
+31
New +$1.19K ﹤0.01% 1451

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Hemington Wealth Management's RVMD Position: Q3 2025 in Review

Hemington Wealth Management increased its Revolution Medicines (RVMD) stake by 58% in Q3 2025, buying an estimated $705 and bringing the position to 49 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Hemington Wealth Management first reported a position in RVMD in Q2 2025 and has held it in 2 quarters since. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Hemington Wealth Management held 49 shares of Revolution Medicines worth $2K as of Q3 2025.
  • Hemington Wealth Management bought 18 Revolution Medicines shares in Q3 2025, an estimated $705.
  • Revolution Medicines made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1365 holding.
  • Hemington Wealth Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 2 quarters since.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.